Ignite Creation Date:
2024-05-06 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05718297
Status:
WITHDRAWN
Last Update Posted:
2024-07-12
First Post:
2023-01-30
Brief Title:
Brigatinib Post Definitive Chemo-radiotherapy in Patients with ALK-fusion Non-small Cell Lung Cancer
Sponsor:
ETOP IBCSG Partners Foundation
Organization:
ETOP IBCSG Partners Foundation
Organization Data
Organization:
ETOP IBCSG Partners Foundation
Class:
NETWORK
Study ID:
ETOP 21-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ETOP IBCSG Partners Foundation
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Takeda | INDUSTRY |